| Health / Medical Topics |
Docetaxel-PNP
A polymeric nanoparticle (PNP) formulation containing the taxane docetaxel, a semi-synthetic analogue of paclitaxel, with antineoplastic activity. Docetaxel binds specifically to the beta-tubulin subunit of the microtubule, stabilizing tubulin and inhibiting microtubule disassembly, which results in cell-cycle arrest at the G2/M phase, preventing cell proliferation. This agent also inhibits pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and induces various mediators of the inflammatory response. Compared to docetaxel alone, the PNP formulation may enhance stability and improve delivery. (NCI Thesaurus)
YOU MAY ALSO LIKE
A regimen consisting of docetaxel and gemcitabine used to treat advanced-stage non-small cell lung cancer.
A regimen consisting of docetaxel and estramustine used for the treatment of metastatic hormone-refractory prostate cancer. Additional steroids such as dexamethasone…
A chemotherapy combination used to treat certain types of head and neck cancer and stomach cancer. It includes the drugs docetaxel (Taxotere),…
A regimen consisting of cisplatin and docetaxel used to treat advanced-stage non-small cell lung cancer and squamous cell head and neck…
A regimen consisting of carboplatin and docetaxel used to treat advanced-stage non-small cell lung cancer. Also used for the treatment of advanced-stage,…
A lipid microsphere (LM)-based formulation containing the poorly water soluble taxane docetaxel, a semi-synthetic analogue of paclitaxel, with antineoplastic activity. Docetaxel binds…
